Below summarizes the voting results by the FDA and PCAC: Some key points: Several PCAC and FDA members voiced concerns regarding the lack of evidence on the safety and efficacy of the peptides in question, the lack of robust evidence in humans generally, and the lack of clarity on exact characteristics (e.g

Seek emergency help immediately (call 999) if, after using any unlicensed peptide compound, you experience any of the following life-threatening symptoms: Signs of anaphylaxis: rash, swelling of the face, lips, or throat, difficulty breathing, or sudden collapse Severe chest pain or palpitations Signs of serious infection (sepsis): high fever, confusion, rapid breathing, or mottled skin following an injection Contact NHS 111 for urgent advice (when symptoms are not immediately life-threatening) if you experience: Persistent or severe nausea, vomiting, or abdominal pain Signs of infection at an injection site: increasing redness, warmth, swelling, pus, or fever Dizziness, fainting, or unexplained changes in blood glucose or metabolic function It is also advisable to inform your GP if you are using or considering any research peptides, even if you feel well
Duration : The session lasts approximately 10 to 20 minutes
Are these peptides now legal to buy